Cite
Rational Design of a Low Molecular Weight, Stable, Potent, and Long-Lasting GPR103 Aza-β3-pseudopeptide Agonist
MLA
Laure Guilhaudis, et al. “Rational Design of a Low Molecular Weight, Stable, Potent, and Long-Lasting GPR103 Aza-Β3-Pseudopeptide Agonist.” Journal of Medicinal Chemistry, vol. 55, Aug. 2012, pp. 7516–24. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....a94d5c8a5b5e442bb7e7c4049afd7859&authtype=sso&custid=ns315887.
APA
Laure Guilhaudis, Jean-Claude do-Rego, Adèle Bourmaud, Jean A. Boutin, Michèle Baudy-Floc’h, Patrick Bauchat, David Vaudry, Olivier Tasseau, Philippe Chan, Isabelle Ségalas-Milazzo, Cindy Neveu, Jean Costentin, Hubert Vaudry, Julien Chuquet, Olivier Le Marec, Jérôme Leprince, & Benjamin Lefranc. (2012). Rational Design of a Low Molecular Weight, Stable, Potent, and Long-Lasting GPR103 Aza-β3-pseudopeptide Agonist. Journal of Medicinal Chemistry, 55, 7516–7524.
Chicago
Laure Guilhaudis, Jean-Claude do-Rego, Adèle Bourmaud, Jean A. Boutin, Michèle Baudy-Floc’h, Patrick Bauchat, David Vaudry, et al. 2012. “Rational Design of a Low Molecular Weight, Stable, Potent, and Long-Lasting GPR103 Aza-Β3-Pseudopeptide Agonist.” Journal of Medicinal Chemistry 55 (August): 7516–24. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....a94d5c8a5b5e442bb7e7c4049afd7859&authtype=sso&custid=ns315887.